Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.37
- Piotroski Score 1.00
- Grade Buy
- Symbol (DERM)
- Company Journey Medical Corporation
- Price $5.41
- Changes Percentage (3.94%)
- Change $0.21
- Day Low $5.11
- Day High $5.65
- Year High $8.11
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.17
- Trailing P/E Ratio -27.65
- Forward P/E Ratio -27.65
- P/E Growth -27.65
- Net Income $-3,853,000
Income Statement
Quarterly
Annual
Latest News of DERM
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Biden admin exec order allowing US to sanction Americans undermining West Bank 'stability' prompts lawsuit
A lawsuit challenges the Biden administration's executive order imposing sanctions on American Jews in the West Bank, claiming it violates constitutional rights. Critics argue the sanctions target tho...
By Fox News | 1 day ago -
McDermott wins sustainable aviation fuel facilities contract in UK
McDermott secures a contract with Willis Sustainable Fuels (UK) for sustainable aviation fuel facilities in the UK. The project involves early engineering, procurement, and construction of a facility ...
By Yahoo! Finance | 2 days ago -
Dermapharm Holding Third Quarter 2024 Earnings: EPS: €0.60 (vs €0.46 in 3Q 2023)
The chart displays figures for the trailing 12 months. Revenue is expected to grow by 4.0% annually for the next 3 years, exceeding the Pharmaceuticals industry in Germany. However, 2 warning signs ha...
By Yahoo! Finance | 6 days ago
